Skip to content
Biodatica
Start free

Investigator

Susan M Majka

GORDON RESEARCH CONFERENCES · funded by NHLBI, NIA

Companies
3

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$3.3M

Summed across those awards.

First award
Jan 1, 2022

Latest Jul 24, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    2025 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar

    $10k

    Jul 24, 2025NHLBIGORDON RESEARCH CONFERENCESNIH RePORTER · 11074259 (opens the source filing in a new tab)

  2. R01

    Loss of progenitor function accelerates lung aging

    $673k

    Jun 15, 2023NIANATIONAL JEWISH HEALTHNIH RePORTER · 11047760 (opens the source filing in a new tab)

  3. R01

    Loss of progenitor function accelerates lung aging

    $685k

    Jun 15, 2023NIANATIONAL JEWISH HEALTHNIH RePORTER · 11381699 (opens the source filing in a new tab)

  4. R35

    Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema

    $996k

    Jan 1, 2022NHLBINATIONAL JEWISH HEALTHNIH RePORTER · 11017855 (opens the source filing in a new tab)

  5. R35

    Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema

    $976k

    Jan 1, 2022NHLBINATIONAL JEWISH HEALTHNIH RePORTER · 11257257 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources